Global In Vitro Fertilization (IVF) Market (Instruments, Reagents and Media, Technology, Geography) - Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research, Report, Company Profiles, Segmentation and Forecast, 2013 - 2020

Global In Vitro Fertilization (IVF) Market (Instruments, Reagents and Media, Technology, Geography) - Size, Share, Trends, Opportunities, Global Deman

Category : Medical Devices
Published On : February  2014
Pages : 106



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

IVF is also known as In-Vitro Fertilization. In this process, sperm and egg together are fused into Petri Dish. After successful fertilization, IVF treatment is complete.

In 2012, global IVF market had a value of $9.3 billion. It is further forecast to reach $21.6 billion by the end of 2020. Late marriages and pregnancy cases among women are enhancing the Global IVF Market since fertility reduces with age. Some other factors that work positively for Global IVF market are changing lifestyles, rise in stress levels, smoking etc. As per the global data, number of infertile couple worldwide was 48.5 million in 2010. Further, there is a higher success rate of pregnancy in the age group 35-39 with IVF treatment.

High cost that IVF treatment demands is one major factor impeding force for global IVF market due to a higher possibility of infertile couple not conceiving in in the first IVF cycle. Patient would require to undergo multiple IVF cycles to become pregnant, which increases the total cost of IVF treatment. Approximate cost for IVF procedure would be around $10,000-$20,000 and hence, in nation with low income groups, IVF treatment has a lesser scope. Less awareness about the IVF treatment in developing nations such as Nigeria also poses a stiff challenge for Global IVF market. In order to increase the awareness. Medical tourism and low cost IVF procedure must be encouraged.

Below are dominant market player in IVF market:

  • Vitrolife AB,
  • Cook Medicals,
  • Cooper Surgical. Inc
  • Thermo Scientific,
  • GeneaBiomedx,
  • Irvine Scientific Inc
  • Oxford Gene Technology
  • EMD SeronoInc
  • Ova Science
  • AuxogynInc

 KEY BENEFITS

  • Detailed analysis of the global IVF market, segmentation based on reagents and media,technology,instruments, geographies and end users.
  • Quantitative breakdown of the present market trends and analysis during the forecast period of 2013-2020   
  • Valuation and classification of the factors that affect global IVF market and detailed analysis of the impact by such factors  
  • Identifying key investment region for the market that would offer assistance to firms hoping a high return on investment
  • Based on porter’s five force analysis, this report presents the study of the trading power of suppliers and bargaining power of buyers in the market
  • Depending on value chain analysis, this report provides a detailed analysis of intermediaries
  • This report presents an in-depth analysis of different geographical locations affecting global IVF market
  • SWOT analysis of the important market players that would help investors to know trends their competitors follow and accordingly take appropriate decisions

KEY AUDIENCES

  • Fertility clinics
  • Instruments and reagent manufacturers
  • Hospitals
  • Government and private institutes
  • Cryopreservation banks

 

CHAPTER 1 INTRODUCTION

1.1 Key Benefits
1.2 Key Audiences
1.3 Research Methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL IVF MARKET OVERVIEW

3.1 Market definition and scope
3.2 Alternative technologies

3.2.1 IUI technique

3.2.1.1 Factors assessed for the procedure
3.2.1.2 Reasons for use of the technique
3.2.1.3 Benefits of this technique
3.2.1.4 Risks

3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique

3.2.3.1 Difference between GIFT and IVF technique

3.2.4 ZIFT technique

3.2.4.1 Differences between ZIFT and IVF technique

3.3 Replacing IVF procedures by fertility drugs and surgeries

3.3.1 Female infertility treatments

3.3.1.1 Limitations of fertility drugs

3.3.2 Male infertility treatments

3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market

3.5.1 Egg donation

3.5.1.1 Egg sharing

3.5.2 Sperm donation
3.5.3 Embryo donation
3.5.4 Donation for research

3.6 Surrogacy

3.6.1 Legal issues

3.7 Rise in same sex couples

3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization

3.8 Advanced technologies in IVF

3.8.1 Capsule IVF
3.8.2 Three parent IVF

3.8.2.1 Ethical concerns

3.8.3 Mini IVF

3.8.3.1 Advantages
3.8.3.2 Drawbacks

3.8.4 EmbryoScope

3.8.4.1 Advantages

3.8.5 PICSI

3.9 Fertility treatment and Gender selection

3.9.1 Methods of sex selection

3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues

3.10 Metabolomics in embryo screening methods

3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Top ten factors impacting IVF market
3.14 Top winning strategies in the IVF market
3.15 Porter’s five forces analysis

3.15.1 Competition declining suppliers power
3.15.2 Availability of options impacting buyer power
3.15.3 High cost -a hindrance to new entrants
3.15.4 Application of strategies to overcome competition
3.15.5 Inefficient threat from substitutes

3.16 Value chain analysis
3.17 Insurance reimbursement Scenario
3.18 Regulatory issues and legislations
3.19 Clinical trials

3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures

3.20 Market dynamics

3.20.1 Drivers

3.20.1.1 Age
3.20.1.2 Rise in infertility rates
3.20.1.3 Advancement in technology
3.20.1.4 Rise in donation
3.20.1.5 Increase in average income
3.20.1.6 Increase in success rates

3.20.2 Restraints

3.20.2.1 Physical and emotional impact
3.20.2.2 Ethical and legal issues
3.20.2.3 Cost of the treatment
3.20.2.4 Multiple pregnancies
3.20.2.5 Low awareness level

3.20.3 Opportunities:

3.20.3.1 Medical tourism
3.20.3.2 New technology trends
3.20.3.3 Rise in same sex marriages

CHAPTER 4 GLOBAL IVF MARKET BY INSTRUMENTS

4.1 Global IVF market by instruments types, 2012-2020,$million
4.2 Global IVF instruments market, by geography, 2012-2020, $million
4.3 Incubators

4.3.1 Global IVF incubators market , by geography, 2012-2020, $million

4.4 Cryosystem

4.4.1 Global IVF cryosystem market, by geography, 2012-2020, $million

4.5 Imaging system

4.5.1 Global IVF Imaging system market , by geography, 2012-2020, $million

4.6 Cabinet( work station)

4.6.1 Global IVF cabinets market , by geography, 2012-2020, $million

4.7 Ovum Aspiration pump

4.7.1 Global IVF ovum aspiration pump market , by geography, 2012-2020, $million

4.8 Sperm separation system

4.8.1 Global IVF Sperm seperation system market, by geography, 2012-2020, $million

4.9 Accessories and disposables

4.9.1 Semen analysis chamber
4.9.2 Plastic ware
4.9.3 Oocyte retrieval needles
4.9.4 Miscellaneous disposables
4.9.5 Global IVF accessories and disposable market , by geography, 2012-2020, $million

4.10 Micro Manipulator System

4.10.1 Global IVF Micromanipulator market , by geography, 2012-2020, $million

4.11 Others

4.11.1 Refrigerators

4.11.1.1 Global IVF other instruments market , by geography, 2012-2020, $million

CHAPTER 5 GLOBAL IVF MARKET BY REAGENTS AND MEDIA

5.1 Global IVF market by reagents and media types,2012-2020,$million
5.2 Global IVF reagents and media market, by geography, 2012-2020, $million
5.3 Cryopreservation media

5.3.1 Embryo cryopreservation media
5.3.2 Sperm cryopreservation media
5.3.3 Oocyte cryopreservation media

5.3.3.1 Disadvantage
5.3.3.2 Advantages

5.3.4 Global IVF cryopreservation media market , by geography, 2012-2020, $million

5.4 Semen processing media

5.4.1 Global IVF semen processing media market , by geography, 2012-2020, $million

5.5 Ovum processing media

5.5.1 Global IVF ovum processing media market , by geography, 2012-2020, $million

5.6 Embryo culture media

5.6.1 Global IVF embryo culture media market , by geography, 2012-2020, $million

CHAPTER 6 GLOBAL IVF MARKET BY TECHNOLOGY

6.1 Global IVF market, by technology, 2012-2020, $million
6.2 Global IVF technology market, by geography, 2012-2020, $million
6.3 PGD technique

6.3.1 Drivers
6.3.2 Restraints
6.3.3 Global IVF pre-implantation genetic diagnosis market , by geography, 2012-2020, $million

6.4 FER technique

6.4.1 Reasons to use this technique
6.4.2 Advantages of FER technique
6.4.3 Disadvantages of FER technique

6.4.4 Global IVF Frozen embryo replacement market , by geography, 2012-2020, $million

6.5 ICSI Technique

6.5.1 Benefits
6.5.2 Risks
6.5.3 Global IVF intra cytoplasmic sperm injection market , by geography, 2012-2020, $million

6.6 Others:

6.6.1 Global IVF other technology market , by geography, 2012-2020, $million
6.6.2 IVM Technique
6.6.3 Assisted hatching

CHAPTER 7 GLOBAL IVF MARKET BY END USERS

7.1 Global IVF market by end users, 2012-2020, $million
7.2 Global IVF end use market, by geography, 2012-2020, $million
7.3 Hospitals

7.3.1 Global IVF Hospitals market , by geography, 2012-2020, $million

7.4 Clinics

7.4.1 Global IVF Clinics market , by geography, 2012-2020, $million

7.5 Surgical centers

7.5.1 Global IVF Surgical centers market , by geography, 2012-2020, $million

7.6 Clinical research institutes

7.6.1 Global IVF clinical research institutes market , by geography, 2012-2020, $million

7.7 Banks

7.7.1 Global IVF banks market , by geography, 2012-2020, $million

CHAPTER 8 IVF MARKET BY GEOGRAPHY

8.1 Europe
8.2 North America

8.2.1 North American IVF market, 2012-2020, $million

8.3 Asia pacific

8.3.1 Asia Pacific IVF market, 2012-2020, $million

8.4 RoW

8.4.1 RoW IVF market, 2012-2020, $million

CHAPTER 9 COMPANY PROFILES

9.1 Vitrolife AB

9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Business performance
9.1.4 Strategic moves and developments

9.1.4.1 Primary strategies: regulatory approvals, acquisition and agreements
9.1.4.2 Others

9.1.5 SWOT Analysis of Vitrolife AB

9.2 EMD Serono, Inc

9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Strategic moves and developments

9.2.4.1 Primary strategies

9.2.5 SWOT Analysis of EMD Serono, Inc

9.3 Irvine scientific

9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Strategic moves and developments

9.3.4.1 Primary strategy: FDA approvals

9.3.5 SWOT Analysis of Irvine scientific

9.4 Cooper Surgical, Inc.

9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Strategic moves and developments

9.4.4.1 Primary strategies

9.4.5 SWOT Analysis of Cooper Surgical, Inc

9.5 Cook Medical, Inc

9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Strategic moves and developments

9.5.3.1 Primary strategies

9.5.4 SWOT Analysis of Cook medical

9.6 Thermo Fisher Scientific Inc.

9.6.1 Company overview:
9.6.2 Company snapshot
9.6.3 Business Performance
9.6.4 Strategic moves and developments

9.6.4.1 Primary strategy: product launch

9.6.5 SWOT Analysis of Thermo Fisher Scientific Inc.

9.7 Genea Biomedx

9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Strategic moves and developments

9.7.3.1 Primary strategy: product launch

9.7.4 SWOT Analysis of Genea Biomedx

9.8 Auxogyn, Inc

9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Strategic moves and developments

9.8.3.1 Primary strategies- Agreement and partnership
9.8.3.2 Others strategies

9.8.4 SWOT Analysis of Auxogyn, Inc

9.9 Oxford Gene Technology

9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Strategic moves and developments

9.9.3.1 Primary strategy: product launch

9.9.4 SWOT analysis of oxford gene technology

9.10 Ovascience

9.10.1 Company overview
9.10.2 Business Performance
9.10.3 Strategic moves and developments

9.10.3.1 Primary strategy

9.10.4 SWOT analysis of Ovascience

 

LIST OF TABLES:

TABLE 1  GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 2  INSURANCE COVERAGE FOR COUNTRIES
TABLE 3  GLOBAL IVF MARKET BY INSTRUMENTS TYPES,2012-2020,$MILLION
TABLE 4  GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 5  GLOBAL IVF INCUBATORS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 6  GLOBAL IVF CRYOSYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 7  GLOBAL IVF IMAGING SYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 8  GLOBAL IVF CABINETS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 9  GLOBAL IVF OVUM APIRATION PUMP MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 10  GLOBAL IVF SPERM SEPERATION SYSTEM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 11  GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 12  GLOBAL IVF MICROMANIPULATOR MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 13  GLOBAL IVF OTHER INSTRUMENTS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 14  GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES,2012-2020,$MILLION
TABLE 15  GLOBAL IVF REAGENTS AND MEDIA MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 16  CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 17  GLOBAL IVF CRYOPRESERVATION MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 18  GLOBAL IVF SEMEN PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 19  GLOBAL IVF OVUM PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 20  EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 22  GLOBAL IVF EMBRYO CULTURE MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 23  GLOBAL IVF MARKET, BY TECHNOLOGY, 2012-2020, $MILLION
TABLE 24  GLOBAL IVF TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 25  GLOBAL IVF PRE-IMPLANTATION GENETIC DIAGNOSIS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 26  GLOBAL IVF FROZEN EMBRYO REPLACEMENT MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 27  GLOBAL IVF INTRA CYTOPLASMIC SPERM INJECTION MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 28  GLOBAL IVF OTHER TECHNOLOGY MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 29  GLOBAL IVF MARKET BY END USERS,2012-2020,$MILLION
TABLE 30  GLOBAL IVF END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 31  GLOBAL IVF HOSPITALS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 32  GLOBAL IVF CLINICS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 33  GLOBAL IVF SURGICAL CENTERS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 34  GLOBAL IVF CLINICAL RESEARCH INSTITUTES MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 35  GLOBAL IVF BANKS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 36  EUROPE’S ACTIVE COUNTRIES FOR IVF TREATMENT, 2010
TABLE 37  EMEA IVF MARKET, 2012-2020, $MILLION
TABLE 38  NORTH AMERICAN IVF MARKET, 2012-2020, $MILLION
TABLE 39  ASIA PACIFIC IVF MARKET, 2012-2020, $MILLION
TABLE 40  ROW IVF MARKET, 2012-2020, $MILLION
TABLE 41  SNAP SHOT OF VITROLIFE AB
TABLE 42  SNAP SHOT OF EMD SERONO, INC
TABLE 43  SNAP SHOT OF IRVINE SCIENTIFIC
TABLE 44  SNAP SHOT OF COOPER SURGICAL, INC
TABLE 45  SNAP SHOT OF COOK MEDICAL
TABLE 46  SNAP SHOT OF THERMO FISHER SCIENTIFIC INC
TABLE 47  SNAP SHOT OF GENEA BIOMEDX
TABLE 48  SNAP SHOT OF AUXOGYN, INC
TABLE 49  SNAP SHOT OF OXFORD GENE TECHNOLOGY
TABLE 50  SNAP SHOT OF OVASCIENCE

 

LIST OF FIGURES:

FIG. 1  IUI SUCCESS RATES BY AGE UK, 2010
FIG. 2  HIGH ORDER BIRTH RATES: MEDICALLY ASSISTED VS IVF TECHNIQUE
FIG. 3  COST OF BASIC IVF TYPE PROCEDURES
FIG. 4  PERCENTAGE OF LIVE BIRTH USING DONOR EGGS, U.S.A, 2011
FIG. 5  LIVE BIRTH RATE PER CYCLE USING DONOR SPERM, U.K. 2010
FIG. 6  EMBRYOS CREATED USING DONOR EGGS, EUROPE
FIG. 7  ADOPTION RATE BY TYPE OF SURROGACY
FIG. 8  TOP FACTORS IMPACTING IVF MARKET (2013-2020)
FIG. 9  TOP WINNING STRATEGIES OF IVF MARKET (2010-2013)
FIG. 10  PORTER’S FIVE FORCE ANALYSIS:
FIG. 11  VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIG. 12  EFFECT OF AGE ON FERTILITY
FIG. 13  COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIG. 14  SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE ,2011,U.S.A
FIG. 15  PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2011 (USA)
FIG. 16  LIVE BIRTH RATE PER CYCLE, AFTER FROZEN EMBRYO TRANSFER, 2011(USA)
FIG. 17  PERCENTAGES OF COUPLES SEEKING ICSI TREATMENT, BY THE REASON THEY SOUGHT TREATMENT, U.S.A ,2011
FIG. 18  PERCENTAGE OF CYCLES RESULTING IN LIVE BIRTHS (2010) U.K
FIG. 19  POLICIES PROVIDED BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
FIG. 20  SALES PER REGION 2012
FIG. 21  SWOT ANALYSIS OF VITROLIFE AB
FIG. 22  SALES BY REGION, 2012
FIG. 23  SWOT ANALYSIS OF EMD SERONO, INC
FIG. 24  SWOT ANALYSIS OF IRVINE SCIENTIFIC
FIG. 25  SWOT ANALYSIS OF COOPER SURGICAL, INC
FIG. 26  SWOT ANALYSIS OF COOK MEDICAL
FIG. 27  FINANCIAL REVENUES BY BUSINESS UNITS (2012)
FIG. 28  FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 29  SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC INC.
FIG. 30  SWOT ANALYSIS OF GENEA BIOMEDX
FIG. 31  SWOT ANALYSIS OF AUXOGYN, INC
FIG. 32  SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIG. 33  SWOT ANALYSIS OF OVASCIENCE

Enquiry Before Buy
image
Can´t read the image ? refresh here.